Alpha2-adrenergic agonists for the management of opioid withdrawal (Review)
保存先:
Gowing, I., et al., Alpha2-adrenergic agonists for the management of opioid withdrawal (Review). Oxford, Cochrane Tobacco Addiction Group, 2014, 87 p.
Ref.
500892
配架場所:
SIIS Archivo
Palabras clave:
Drogodependencias, Drogas ilegales, Opiáceos, Programas de desintoxicación, Opiáceos, Fármacos, Tratamiento médico, Efectos, Resultados, Evaluación de servicios, Literatura científica
Drogodependencias, Drogas ilegales, Opiáceos, Programas de desintoxicación, Opiáceos, Fármacos, Tratamiento médico, Efectos, Resultados, Evaluación de servicios, Literatura científica
類似資料: Alpha2-adrenergic agonists for the management of opioid withdrawal (Review)
- ADRENERGIC AGONISTS IN OPIOID WITHDRAWAL
- A COMPARISON OF METHADONE, BUPRENORPHINE AND ALPHA ADRENERGIC AGONIST FOR OPIOID DETOXIFICATION: A MIXED TREATMENT COMPARISON META ANALYSIS
- A PHASE 3 PLACEBO-CONTROLLED, DOUBLE-BLIND, MULTI-SITE TRIAL OF THE ALPHA-2-ADRENERGIC AGONIST, LOFEXIDINE, FOR OPIOID WITHDRAWAL
- THE MANAGEMENT OF OPIOID WITHDRAWAL
- Opioid agonist treatment for pharmaceutical opioid dependent people (Review)
- Interim opioid agonist treatment for opioid addiction: a systematic review